MPHOSPH8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.704600E-01
Normal-vs-Stage2
4.075600E-01
Normal-vs-Stage3
3.004000E-01
Normal-vs-Stage4
4.170800E-01
Stage1-vs-Stage2
3.766200E-01
Stage1-vs-Stage3
3.881700E-02
Stage1-vs-Stage4
1.289380E-01
Stage2-vs-Stage3
2.255700E-03
Stage2-vs-Stage4
1.959800E-02
Stage3-vs-Stage4
2.183700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.117800E-01
Normal-vs-AfricanAmerican
6.981200E-01
Normal-vs-Asian
4.919400E-01
Caucasian-vs-AfricanAmerican
7.340800E-01
Caucasian-vs-Asian
7.001600E-01
AfricanAmerican-vs-Asian
6.764400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.153200E-01
Normal-vs-Female
4.790200E-01
Male-vs-Female
9.630400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.344000E-01
Normal-vs-Age(41-60Yrs)
7.619400E-01
Normal-vs-Age(61-80Yrs)
3.375600E-01
Normal-vs-Age(81-100Yrs)
1.807760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.945800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.148600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.025000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.731500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.911600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.642600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.949590E-01
Normal-vs-Daily Drinker
9.751800E-02
Normal-vs-Weekly Drinker
1.956440E-01
Normal-vs-Occasional Drinker
6.134600E-01
Normal-vs-Social Drinker
9.160000E-01
Non Drinker-vs-Daily Drinker
5.195400E-01
Non Drinker-vs-Weekly Drinker
7.165200E-01
Non Drinker-vs-Occasional Drinker
9.581500E-02
Non Drinker-vs-Social Drinker
1.155580E-01
Daily Drinker-vs-Weekly Drinker
8.677200E-01
Daily Drinker-vs-Occasional Drinker
2.574300E-02
Daily Drinker-vs-Social Drinker
5.628400E-02
Weekly Drinker-vs-Occasional Drinker
8.904200E-02
Weekly Drinker-vs-Social Drinker
9.748300E-02
Occasional Drinker-vs-Social Drinker
6.116000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.550200E-02
Normal-vs-Grade 2
1.281940E-02
Normal-vs-Grade 3
7.161000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.776400E-01
Grade 1-vs-Grade 3
9.594400E-01
Grade 1-vs-Grade 4
3.550200E-02
Grade 2-vs-Grade 3
7.749600E-01
Grade 2-vs-Grade 4
1.281940E-02
Grade 3-vs-Grade 4
7.161000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.662800E-01
Normal-vs-NonDiabetic
3.298200E-01
Diabetic-vs-NonDiabetic
8.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.471800E-01
Normal-vs-NoPancreatitis
3.402400E-01
Pancreatitis-vs-NoPancreatitis
8.962200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.410000E-01
Normal-vs-N1
3.703000E-01
N0-vs-N1
2.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.704000E-01
Normal-vs-TP53-NonMutant
7.434600E-01
TP53-Mutant-vs-TP53-NonMutant
8.050000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
